Identity
- Security key
- 12079
- Ticker
- AVBP
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2024-01-26
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- AVBP
Detail
Enriched 2026-08-14 20:47
- Market cap
- $1,465,247,234.88
- Shares outstanding (class)
- 46,574,928
- Shares outstanding (weighted)
- 46,574,928
- SIC
- 2834 PHARMACEUTICAL PREPARATIONS
- Employees
- 77
- Location
- NEWTOWN SQUARE, PA
- Homepage
- https://www.arrivent.com
- Description
ArriVent BioPharma Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. The company focuses on advancing its lead product candidate, firmonertinib, for the treatment of epidermal growth factor receptor (EGFR) mutant non-small cell lung cancer (NSCLC), and developing a pipeline of novel therapeutics, including next-generation antibody-drug conjugates such as ARR-217 (MRG007), with an initial focus on solid tumors.
Market cap and share counts drift.